Medica Halstabletten Honig

Chlorhexidine Dihydrochloride and Lidocaine Hydrochloride, the active ingredients in Medica Halstabletten Honig, are an antiseptic and a local anesthetic presented as oral lozenges for oromucosal use. They provide antimicrobial action and temporary relief of throat discomfort in adults and children, offering a safe, short‑term option for symptom management.

GNH USA supplies Medica Halstabletten Honig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured under EU GMP standards and is intended for short‑term symptomatic relief of oral discomfort.

Medica Halstabletten Honig combines chlorhexidine and lidocaine to address oral mucosal discomfort and infection.

- Sore throat: provides temporary pain relief and reduces microbial load in the pharyngeal area. - Oral ulcerations: eases discomfort and helps prevent secondary infection of mouth sores. - Post‑operative oral care: offers antiseptic protection and local anaesthesia after dental or surgical procedures.

Adverse reactions to Medica Halstabletten Honig are generally mild, but some users may experience more serious effects.

Common Side Effects: - Altered taste: temporary metallic or sweet taste. - Oral irritation: mild burning or tingling. - Transient numbness: brief loss of sensation on the tongue or palate. - Nausea: mild upset stomach after dissolution.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical care. - Severe mucosal ulceration: extensive ulcer formation in the oral cavity. - Respiratory depression: rare systemic lidocaine toxicity affecting breathing. - Cardiac arrhythmia: rare lidocaine‑related heart rhythm disturbance.

When using Medica Halstabletten Honig, follow these safety measures.

- Indication: use only as directed for short‑term relief of oral discomfort. - Age restriction: avoid use in children under 6 years unless advised by a healthcare professional. - Allergy: do not use if known hypersensitivity to chlorhexidine, lidocaine, or any excipients. - Systemic exposure: limit frequency to prevent excessive lidocaine absorption, especially in patients with hepatic impairment. - Cardiac considerations: caution in patients with known conduction disorders or taking other lidocaine‑containing products. - Store at room temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Potential drug interactions with Medica Halstabletten Honig should be considered.

Major Interactions (Avoid): - Concurrent use of other topical anesthetics containing lidocaine: risk of cumulative systemic toxicity. - Systemic lidocaine‑containing medications (e.g., antiarrhythmics): may increase lidocaine plasma levels. - Other chlorhexidine products (mouthwash, topical solutions): may cause excessive local irritation.

Moderate Interactions (Monitor Closely): - Antihistamines or other drugs that lower the seizure threshold: may increase risk of lidocaine‑related neurotoxicity. - Beta‑blockers: potential additive effect on heart rate when systemic lidocaine is absorbed. - Alcohol‑containing beverages: may enhance mucosal irritation.